PRNewsWire
28 May 2026, 20:40 UTC · 2h ago
Perimeter Announces First Quarter 2026 Financial Results
Source · https://www.prnewswire.com/news-releases/perimeter-announces-first-quarter-2026-financial-results-302785009.html
Read source
Search tags
PRNewsWire
28 May 2026, 20:40 UTC · 2h ago
Source · https://www.prnewswire.com/news-releases/perimeter-announces-first-quarter-2026-financial-results-302785009.html
Read sourceSearch tags
Story key points
4 claims · impact-rated
Perimeter has begun commercial placements of its FDA PMA-approved, AI-enabled Claire OCT device in US healthcare institutions. — The transition from legacy products to the commercial launch of a next-generation, FDA-approved AI device is the primary catalyst for future revenue growth.
+0.80The company successfully completed a 'Life Offering' and a first tranche of a Debenture Offering in April and May 2026, raising approximately $7.5 million from the latter. — Fresh capital from institutional investors mitigates immediate liquidity risk for a company with a low cash balance ($421k) and ongoing quarterly losses.
+0.60First quarter 2026 net loss was reduced by 31% to approximately $3.0 million compared to the same period in 2025. — Improved operating performance and a 30% reduction in operating expenses signal better fiscal discipline during the transition phase.
+0.30Continue reading
6 related stories
Q1 2026 revenue decreased to $385,000 from $550,000 in Q1 2025, though all current revenue is now recurring. — The absolute revenue decline is a negative trend, although the shift toward a 100% recurring revenue model is a structural positive.
-0.20Ticker attribution
Model heads
The company reported a 31% improvement in net loss, reduced operating expenses, and progress with its FDA-approved AI device.
No ticker relationship head found.
Impact vectors
1 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
CNBC
38m ago
